Literature DB >> 21351270

Fifty years of cancer incidence: CI5 I-IX.

D Max Parkin1, Jacques Ferlay, Maria-Paula Curado, Freddie Bray, Brenda Edwards, Hai-Rim Shin, David Forman.   

Abstract

The Cancer Incidence in Five Continents (CI5) series comprises nine volumes that bring together peer-reviewed results from population-based cancer registries worldwide. The aim of each is to make available comparable data on cancer incidence from as wide a range of geographical locations as possible. In addition, the existence of long time series of data allows the evolution of risk in different populations over time to be studied. The CI5 I-IX database brings together the results from all nine volumes, spanning a period of some 50 years. In addition, unpublished annual data, with more diagnostic detail, are made available for many cancer registries with 15 or more years of recent data. We describe the construction and composition of the CI5 databases, and provide examples of how they can be used to prepare tables and graphs comparing incidence rates between populations. This is the classical role of descriptive statistics: to allow formulation of hypotheses that might explain the observed differences (geographically, over time, in population subgroups) and that can be tested by further study. Such statistics are also essential components in the planning and evaluation of cancer control programmes.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2010        PMID: 21351270     DOI: 10.1002/ijc.25517

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  80 in total

1.  Cancer incidence in Nigeria: a report from population-based cancer registries.

Authors:  Elima Jedy-Agba; Maria Paula Curado; Olufemi Ogunbiyi; Emmanuel Oga; Toyin Fabowale; Festus Igbinoba; Gloria Osubor; Theresa Otu; Henry Kumai; Alice Koechlin; Patience Osinubi; Patrick Dakum; William Blattner; Clement A Adebamowo
Journal:  Cancer Epidemiol       Date:  2012-05-22       Impact factor: 2.984

2.  Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer.

Authors:  Hafeza Akter; Min Park; Oh-Seung Kwon; Eun Joo Song; Won-Sang Park; Min-Jung Kang
Journal:  Tumour Biol       Date:  2015-02-28

3.  Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations.

Authors:  Youngkyu Moon; Kyo Young Lee; Sook Whan Sung; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

4.  The state of cancer epidemiology curricula in postgraduate schools worldwide.

Authors:  Alireza Mosavi-Jarrahi; Ezanollah Azargashb; Yasaman Mousavi-Jarrahi; Mohammad Ali Mohagheghi
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

Review 5.  Salivary gland neoplasms in non-human primates: A case series and brief literature review.

Authors:  Emily Howard; Olga Gonzalez; Sanjeev Gumber; Daniel C Anderson; Shyamesh Kumar; Edward Dick
Journal:  J Med Primatol       Date:  2019-04-02       Impact factor: 0.667

6.  Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death.

Authors:  Hui-Mei Wu; Li-Jie Shao; Zi-Feng Jiang; Rong-Yu Liu
Journal:  Lung       Date:  2016-09-07       Impact factor: 2.584

7.  Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 8.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

Review 9.  Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.

Authors:  Meteb Al-Foheidi; Mubarak M Al-Mansour; Ezzeldin M Ibrahim
Journal:  Med Oncol       Date:  2013-02-19       Impact factor: 3.064

10.  Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.

Authors:  Pei Li; Jian-Xiang Shi; Li-Ping Dai; Yu-Rong Chai; Hong-Fei Zhang; Mutombo Kankonde; Peggy Kankonde; Bao-Fa Yu; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.